Purple Biotech Cash Flow Quality Index
Latest as of June 2026:
-5.68x
Purple Biotech cash flow quality index. Purple Biotech (PPBT) has a Cash Flow Quality Index of -5.68x as of June 2026. Operating cash flow of $-2.50 Million is below net income of $441.00K, suggesting accrual-heavy earnings not yet converted to cash. See PPBT financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
-5.68x
Operating CF / Net Income
Operating Cash Flow
$-2.50 Million
USD
Net Income
$441.00K
USD
Data as of
Jun 2026
Most recent filing
Purple Biotech Cash Flow Quality Index by Year (None–None)
Purple Biotech cash flow quality index by year from None to None. Year-by-year earnings quality comparison for Purple Biotech. For the full cash flow conversion analysis, see cash flow conversion of Purple Biotech.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.